Q4 2020 Ultragenyx Pharmaceutical Inc Earnings and Corporate Update Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter and Full Year 2020 Financial Results and Corporate Update Conference Call.
(Operator Instructions)
I would now like to turn the conference over to your host, Mr. Joshua Higa. Sir, you may begin.
Good afternoon, and welcome to the Ultragenyx Financial Results and Corporate Update Conference Call for the Fourth Quarter and Full Year 2020. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com. I am Joshua Higa, Director of Investor Relations. And joining me on this call today are Emil Kakkis, Chief Executive Officer and President; Camille Bedrosian, Chief Medical Officer; Erik Harris, Chief Commercial Officer; and Mardi Dier, our Chief Financial Officer.
I would like to remind investors that this call will include forward-looking statements within the meaning of the safe harbor provisions of the Private Securities
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
